REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS: Rolls-Royce Up On Huge Emirates Order

Fri, 17th Apr 2015 10:20

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Friday.
-------
FTSE 100 WINNERS
-------
Rolls-Royce Holdings, up 1.3%. The jet engine and power turbine company confirmed it has won its largest ever order, worth USD9.2 billion, to provide engines and support services to Emirates for 50 Airbus A380 aircraft, a deal that breaks the stranglehold that a rival engine maker had on providing engines for the airline's fleet of superjumbo aircraft. Under the deal, the British company will provide Trent 900 engines and TotalCare service support to Emirates, with the engines to power 50 Airbus A380 aircraft due to enter service in 2016.

Pearson, up 1.4%. The educational and publishing group shares are higher after closing as the biggest faller on Thursday on a Wall Street Journal report Wednesday that the Los Angeles school district is to end its use of content provided by Pearson under the Common Core Technology Project.

Whitbread, up 0.6% at 5,256.63 pence. Credit Suisse lifted its price target for the hotel and coffee-shop operator to 6,200 pence from 5,300p, reiterating its Outperform recommendation.

Astrazeneca, up 0.6%. The pharmaceutical giant said the US Food and Drug Administration has granted orphan drug designation for its selumetinib treatment for uveal melanoma, and that the latest data from its ongoing trial of AZD9291 in non-small cell lung cancer shows a delay in disease progression. Separately, Deutsche Bank lifted the company's price target to 4,850 from 4,800, keeping its Hold rating.
-------
FTSE 100 LOSERS
-------
GKN, down 0.5% at 368.8p. Exane BNP downgraded the engineering group to Neutral from Outperform, with a price target of 380p.
-------
FTSE 250 WINNERS
-------
Hunting, up 5.8% at 636.00p. Goldman Sachs upgraded the energy services company to Conviction Buy from Buy, lifting its price target to 709p from 622p.

Qinetiq Group, up 4.8% at 204.5p. Barclays upgraded the defence services company to Overweight from Equal Weight, lifting its price target to 220p from 210p, while Goldman Sachs has slightly raised the company's price target to 208p from 204, reiterating its Hold recommendation.

Debenhams, up 4.3% at 88.57p, having hit a new 16-month high of 89.00p. Several brokers updated their stances on the department store. Citigroup upgraded Debenhams to Buy from Neutral, lifting its price target to 95p from 75p, while SocGen raised the company's price target to 80p from 67p, keeping its Hold rating. Meanwhile, UBS raised its price target to 90p from 85p, reiterating its Buy recommendation. The upgrades come after Debenhams reported a rise in profit for the first half of its financial year, with its shares touching a 15-month high Thursday.
-------
FTSE 250 LOSERS
-------
Indivior, down 2.0% at 208.90p. Deutsche Bank downgraded the former pharmaceutical division of Reckitt Benckiser to Hold from Buy, but lifted its price target to 212p from 180p.
-------
AIM ALL-SHARE WINNERS
-------
Applied Graphene Materials, up 16%. The speciality graphene materials provider said it has received positive preliminary results from independent performance testing conducted on graphene-reinforced polyurethane coatings using graphene it produced. The initial results demonstrate low loading levels of its graphene nanoplatelets substantially enhance the scratch resistance and ultimate tensile strength of a polyurethane clearcoat with minimal damage to transparency or colour, it said.

Zamano, up 10%. The Irish mobile payments and marketing company said it is now an approved direct carrier billing partner for Three Ireland. It said the connection covers all of Three's customers including those obtained during the recent acquisition of O2. Three represents approximately 36% of the mobile market in Ireland according to latest figures, it said.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.